Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP218619.RAim3SHQ0OIZ0tA7tX2VAxaeetK-wfgU00i8-7CTMfgaI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP218619.RAim3SHQ0OIZ0tA7tX2VAxaeetK-wfgU00i8-7CTMfgaI130_assertion type Assertion NP218619.RAim3SHQ0OIZ0tA7tX2VAxaeetK-wfgU00i8-7CTMfgaI130_head.
- NP218619.RAim3SHQ0OIZ0tA7tX2VAxaeetK-wfgU00i8-7CTMfgaI130_assertion description "[When PGRN and MAPT mutation carriers were excluded, there were no significant differences in either the allele or genotype frequencies, or haplotype frequencies, between the FTLD cohort as a whole, or for any clinical diagnostic FTLD subgroup, and 286 controls or between MND cases and controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP218619.RAim3SHQ0OIZ0tA7tX2VAxaeetK-wfgU00i8-7CTMfgaI130_provenance.
- NP218619.RAim3SHQ0OIZ0tA7tX2VAxaeetK-wfgU00i8-7CTMfgaI130_assertion evidence source_evidence_literature NP218619.RAim3SHQ0OIZ0tA7tX2VAxaeetK-wfgU00i8-7CTMfgaI130_provenance.
- NP218619.RAim3SHQ0OIZ0tA7tX2VAxaeetK-wfgU00i8-7CTMfgaI130_assertion SIO_000772 18192287 NP218619.RAim3SHQ0OIZ0tA7tX2VAxaeetK-wfgU00i8-7CTMfgaI130_provenance.
- NP218619.RAim3SHQ0OIZ0tA7tX2VAxaeetK-wfgU00i8-7CTMfgaI130_assertion wasDerivedFrom befree-20140225 NP218619.RAim3SHQ0OIZ0tA7tX2VAxaeetK-wfgU00i8-7CTMfgaI130_provenance.
- NP218619.RAim3SHQ0OIZ0tA7tX2VAxaeetK-wfgU00i8-7CTMfgaI130_assertion wasGeneratedBy ECO_0000203 NP218619.RAim3SHQ0OIZ0tA7tX2VAxaeetK-wfgU00i8-7CTMfgaI130_provenance.